SANFILIPPO JENNIFER A enters MELINTA THERAPEUTICS, INC. /NEW/ with 600.00 shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 9/13/2019ACC: 0001787604-19-000003
DirectorOfficer· interim Chief Executive Office
Since Sep 2019
600.00
Baseline shares
100% direct
600.00
Direct ownership
1 position
125.60K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Melinta Common Stock
DirectShares owned600.00
Total
600.00 direct600.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Melinta Common Stock | 600.00 | Direct |
| Total | 600.00 | 600.00 direct |
Derivative Holdings2
Melinta Restricted Stock Units
DirectUnderlying security
Melinta Common Stock
Underlying shares
120K
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Melinta Stock Option (right to buy)
DirectUnderlying security
Melinta Common Stock
Underlying shares
5.60K
Shares owned
N/A
Exercise price
37.25
Expiration
—
Exercise window
—
Total
Underlying
125.60K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Melinta Restricted Stock Units Direct | Melinta Common Stock | — | — | 120K | N/A | |
| Melinta Stock Option (right to buy) Direct | Melinta Common Stock | 37.25 | — | — | 5.60K | N/A |
| Total | 125.60K | 0.00 | ||||